European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).
Blomström-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG, Poole J, Boriani G, Costa R, Deharo JC, Epstein LM, Saghy L, Snygg-Martin U, Starck C, Tascini C, Strathmore N; ESC Scientific Document Group.
Europace. 2020 Apr 1;22(4):515-549. doi: 10.1093/europace/euz246.
QRS area as a predictor of cardiac resynchronization therapy response: A systematic review and meta-analysis.
Tokavanich N, Prasitlumkum N, Mongkonsritragoon W, Trongtorsak A, Cheungpasitporn W, Chokesuwattanaskul R.
Pacing Clin Electrophysiol. 2022 Mar;45(3):393-400. doi: 10.1111/pace.14441. Epub 2022 Jan 29.
Prognostication of Poor Survival After Cardiac Resynchronization Therapy.
Bašinskas P, Stoškutė N, Gerulytė A, Abramavičiūtė A, Puodžiukynas A, Kazakevičius T.
Medicina (Kaunas). 2020 Jan 4;56(1):19. doi: 10.3390/medicina56010019.
Quality of Life and Type of Cardiac Resynchronization Therapy Device in Older Heart Failure Patients.
Dhande M, Myaskovsky L, Althouse A, Singh M, Weiss R, Shalaby A, Al-Khatib SM, Topoll A, Jain S, Saba S.
J Palliat Med. 2023 Apr;26(4):481-488. doi: 10.1089/jpm.2022.0217. Epub 2022 Nov 8.
Cardiac Resynchronization Therapy prevents progression of renal failure in heart failure patients.
Jeevanantham V, Turagam M, Shanberg D, Reddy M, Atoui M, Daubert JP, Dawn B, Lakkireddy D.
Indian Pacing Electrophysiol J. 2016 Jul-Aug;16(4):115-119. doi: 10.1016/j.ipej.2016.11.006. Epub 2016 Nov 11.
Predictive value of frontal QRS-T angle after cardiac resynchronization therapy.
Gündüz R, Usalp S.
J Electrocardiol. 2021 Sep-Oct;68:24-29. doi: 10.1016/j.jelectrocard.2021.06.015. Epub 2021 Jul 3.
Comparison of Speckle Tracking Echocardiography During Different Pacing Modalities for Cardiac Resynchronization Therapy Response Prediction.
Tejman-Yarden S, Barzilai DH, Ertracht O, Bachner-Heinenzon N, Bogdan S, Katz U, Chatterji S, Dray EM, Bolkier Y, Glikson M, Beinart R.
Heart Int. 2022 Jun 1;16(1):64-70. doi: 10.17925/HI.2022.16.1.64. eCollection 2022.
Optimizing outcomes from cardiac resynchronization therapy: what do recent data and insights say?
de Vere F, Wijesuriya N, Howell S, Elliott MK, Mehta V, Mannakkara NN, Strocchi M, Niederer SA, Rinaldi CA.
Expert Rev Cardiovasc Ther. 2024 Dec 25;22(12):1-18. doi: 10.1080/14779072.2024.2445246. Online ahead of print.
Predictors of Higher Frequency of Atrial Fibrillation in Patients with Cardiac Resynchronization Therapy.
Grbović A, Pavlović S, Žugić V.
Medicina (Kaunas). 2023 Dec 15;59(12):2178. doi: 10.3390/medicina59122178.
The impact of frailty in older patients with non-ischaemic cardiomyopathy after implantation of cardiac resynchronization therapy defibrillator.
Dominguez-Rodriguez A, Abreu-Gonzalez P, Jimenez-Sosa A, Gonzalez J, Caballero-Estevez N, Martín-Casañas FV, Lara-Padron A, Aranda JM Jr.
Europace. 2015 Apr;17(4):598-602. doi: 10.1093/europace/euu333. Epub 2015 Jan 6.
